Pillar Biosciences to Participate in the 2022 UBS Genomics 2.0 and MedTech Innovations Summit
NATICK, Mass. – August 5, 2022 – (BUSINESS WIRE) – Pillar Biosciences, the leader in Decision Medicine™, which develops and distributes next-generation sequencing (NGS) products and technologies to localize testing and reduce time to treatment initiation and overall testing costs, today announced that Randy Pritchard, Chief Executive Officer, will participate in the “Liquid Biopsy in […]